Fareeda Hosein, MD, MBA

BMS
Summit, NJ, United States

Fareeda Hosein MD, MBA is a Senior Director in Early Clinical Development Immunology at Bristol Myers Squibb (BMS) with 15 years of early and late phase drug development experience. She completed her medical training at The Ohio State University College of Medicine and masters in business administration at Rutgers University School of Business. Fareeda has been involved in immunology and oncology clinical development at BMS, holding positions of increasing responsibilities for a broad range of conditions. She has led the early development strategies for immunologic conditions including atopic dermatitis, cutaneous lupus erythematosus, rheumatoid arthritis and inflammatory bowel disease, and late development strategies for oncologic conditions such as advanced melanoma.

Presentation(s):

• L17: Safety, Tolerability, and Exploratory Efficacy of Afimetoran, a TLR7/8 Inhibitor, in Patients with Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study

  Wednesday, November 15, 2023
  8:00 AM – 8:15 AM PT

  Disclosure information not submitted.